Global Vaccine & Immunization Research Forum
04 March 2014,
Washington DC. 4-6 March 2014
The Global Vaccine and Immunization Research forum (GVIRF), co-hosted by the World Health Organisation (WHO), the National Institute of Allergy and Infectious Diseases, and the Bill & Melinda Gates Foundation will be the first gathering for some 250 participants from around the globe working in the field of Research and Development (R&D), as well as policy makers, and other individuals committed to the global vaccination partnership.
The GVIRF will meet to track progress of the WHO’s Global Vaccine Action Plan (GVAP) R&D agenda developed in the framework of the Decade of Vaccines (DoV) Collaboration and endorsed by the 2012 World Health Assembly. This scientific forum aims to identify opportunities and challenges for the vaccine and immunization R&D community; build and strengthen a research community networking; and provide a platform to discuss ways for stakeholders in the development and implementation of an R&D agenda for vaccines to collaborate.
At the GVIRF, the industry’s leading experts will share insights on to the vaccine manufacturers approach to innovative research and the challenges they face to sustain innovation for the development of the still elusive complex vaccines to immunize against HIV/AIDS, tuberculosis, malaria and dengue. They will also give an overview of progress being made by scientists to develop universal influenza vaccines, protection of pregnant women, neonates and infants by maternal immunization, innovation in vaccine delivery and presentation and recent advances in vaccinomics to accelerate next-generation vaccine development.
To learn more about the event, click here